je.st
news
Pfizer 3Q net falls due to generics, higher costs
2013-10-29 13:04:43| Biotech - Topix.net
Pfizer Inc. says third-quarter profit dropped 19 percent as generic competition continued to cut sales, while operational expenses, taxes and charges all rose.
Tags: net
due
costs
higher
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||